外周动脉疾病患者6分钟步行距离的 meaningful 变化阈值
该研究基于三项纵向观察研究,纳入777例外周动脉疾病(PAD)患者,分析6分钟步行距离变化与患者自报步行困难改善或下降程度的关系。结果显示,6分钟步行距离改善约8米和20米分别代表小幅和大幅步行能力改善,而自报步行能力无变化的患者6分钟步行距离平均下降7米。
要点
- 6分钟步行距离改善约8米和20米分别代表PAD患者步行能力的小幅和大幅改善。
- 自报步行能力无变化的PAD患者一年内6分钟步行距离平均下降7米。
- 这些阈值有助于解读PAD步行干预随机试验的结果。
核心结论
- 在PAD患者中,6分钟步行距离改善约8米和20米分别代表步行能力的小幅和大幅改善。
- 自报步行能力无变化的患者一年内6分钟步行距离平均下降7米。
研究设计与样本
- 三项观察性纵向研究,纳入777例PAD患者,平均年龄71.2±8.8岁,平均基线6分钟步行距离350.1±118.1米。
- 基线及1年后完成步行损害问卷(WIQ)距离评分和6分钟步行测试。
主要发现
- 自报各WIQ距离步行困难无变化的患者,6分钟步行距离下降7.2米(95%CI -11.6至-2.8米)。
- 相对无变化者,自报步行能力改善1分和2分的患者6分钟步行距离分别改善7.8米(95%CI -0.3至15.9米)和20.1米(95%CI 1.1至39.2米)。
- 相对无变化者,自报步行困难下降1分和2分的患者6分钟步行距离分别下降11.2米(95%CI -19.0至-3.4米)和23.8米(95%CI -37.4至-10.3米)。
关键数值与推荐
- 6分钟步行距离改善约8米对应WIQ距离评分改善1分,改善约20米对应改善2分。
- 6分钟步行距离下降约7米对应自报步行能力无变化。
临床怎么用
- 临床解读PAD患者6分钟步行距离变化时,可参考约8米和20米作为小幅和大幅改善的阈值。
- 注意自报步行能力无变化的患者6分钟步行距离仍可能下降,需客观评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The 6-minute walk test is a common outcome measure in clinical trials of people with lower extremity peripheral artery disease (PAD). However, what constitutes a meaningful change in the 6-minute walk distance has not been well defined for people with PAD. The present study related the change in the 6-minute walk distance to the degree of participant-reported improvement or decline in the 6-minute walk distance to define a meaningful change in the 6-minute walk distance for those with PAD. METHODS: Participants with PAD from three observational longitudinal studies completed the walking impairment questionnaire (WIQ) distance score and 6-minute walk at baseline and 1 year later. The WIQ distance score measures participants' perceived difficulty walking seven different distances without stopping (ranging from walking around the home to walking 5 blocks) on a 0 to 4 Likert scale, with 0 representing an inability to walk the distance and 4 representing no difficulty. The mean changes in the 6-minute walk distance corresponding to the participants' report of no change, 1-unit change, or 2-unit change, respectively, in the Likert scale score between the baseline and 1-year follow-up measures were calculated for each WIQ distance. RESULTS: A total of 777 participants with PAD (mean age, 71.2 ± 8.8 years; mean baseline 6-minute walk distance, 350.1 ± 118.1 meters) completed 5439 questions about their difficulty walking each WIQ distance at baseline and follow-up. Participants with PAD who reported no change in their difficulty in walking each WIQ distance between baseline and follow-up had a decline of 7.2 meters (95% confidence interval [CI], -11.6 to -2.8 meters) in the 6-minute walk test. Relative to those reporting no change in difficulty walking, the participants reporting 1- and 2-point improvements in walking ability showed 6-minute walk distance improvements of 7.8 meters (95% CI, -0.3 to 15.9 meters) and 20.1 meters (95% CI, 1.1-39.2 meters), respectively. Relative to those reporting no change in walking difficulty, those reporting 1- and 2-point declines in perceived walking difficulty showed declines of -11.2 meters (95% CI, -19.0 to -3.4 meters) and -23.8 meters (95% CI, -37.4 to -10.3 meters) in the 6-minute walk distance. CONCLUSIONS: Among people with PAD, ∼8- and ∼20-meter improvements in the 6-minute walk distance represent small and large improvements in walking ability, respectively. People with PAD who reported no change in their ability to walk distances over 1 year simultaneously declined by a mean of 7 meters in the 6-minute walk test. These findings will be useful for interpreting the results from randomized trials of interventions to improve the walking performance of people with PAD.
引用
- McDermott MM, Tian L, Criqui MH, et al. Meaningful change in 6-minute walk in people with peripheral artery disease. J Vasc Surg. 2020. PMID: 32335305. doi:10.1016/j.jvs.2020.03.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。